Infographics

WHO Recognizes long serving staff in Uganda

Maputo – Mozambique today reached an important milestone in malaria prevention among children with the introduction of the R21 vaccine, which will help reduce malaria cases and save thousands of children’s lives each year. In Africa, one child dies from malaria every minute.

Abuja, 5 August, 2024 - Embarking on a transformational journey towards improving Primary Healthcare services in Nigeria, the World Health Organization (WHO) and the Private Sector Health Alliance of Nigeria (PSHAN) have officially launched a groundbreaking collaboration under the "Adopt-A-Healthcare Facility Programme" (ADHFP).

The magnitude and frequency of disease outbreaks and health emergencies in Africa, coupled with the expansion of diseases such as cholera, Ebola Virus Disease, and Lassa fever, underscore the urgent need for robust preparedness and capacity building among WHO AFRO Member States. Furthermore, persistent outbreaks of vaccine-preventable diseases like measles, meningitis, and yellow fever, along with zoonotic diseases such as Rift Valley fever and anthrax, highlight the importance of maintaining operational readiness.

In a significant stride towards bolstering Zimbabwe's resilience against cholera, the Russian Federation donated a substantial consignment of cholera commodities to the Ministry of Health and Child Care (MoHCC).

Harare - The World Health Organization (WHO) is supporting Zimbabwe’s efforts to decommission cholera treatment centers across the country. This strategic move, funded through the Health Resilience Fund, comes after a significant decline in cholera cases, with the last reported case recorded on 30 June 2024.

Polio remains a critical global public health concern, particularly with the resurgence of circulating vaccine-derived poliovirus type 2 (cVDPV2). In Botswana, the detection of cVDPV2 in environmental surveillance in 2022 and 2023 highlighted vulnerabilities in population immunity. In response, the Botswana National Immunization Technical Advisory Group, BOTSNITAG conducted a rigorous review of scientific evidence, concluding that introducing a second IPV dose would substantially increase immunity among children under two years of age.

Uganda’s Ministry of Health (MoH), in collaboration with the World Health Organization (WHO), convened a two-day performance review meeting to assess the progress of the TB and Leprosy Program (NTLP) for the second quarter of 2024.